Yuexin Hu

No.36 Sanhao Street
Shenyang, 110004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Cholesterolated Rapamycin Prodrug Liposomes Induce Antigen-Specific Tolerance and Enable AAV Redosing.

Cholesterolated Rapamycin Prodrug Liposomes Induce Antigen-Specific Tolerance and Enable AAV Redosing.

Journal: Molecular pharmaceutics

Published: February 12, 2026

RAD21 regulation of the enhancer-promoter chromatin loop of RAD51 promotes PARPi resistance in ovarian cancer.

RAD21 regulation of the enhancer-promoter chromatin loop of RAD51 promotes PARPi resistance in ovarian cancer.

Journal: Journal of translational medicine

Published: February 06, 2026

A risk prediction model for recurrence in patients with borderline ovarian tumor based on artificial neural network: development and validation study.

A risk prediction model for recurrence in patients with borderline ovarian tumor based on artificial neural network: development and validation study.

Journal: Journal of ovarian research

Published: July 12, 2025

Dexamethasone prodrug cyclodextrin aggregates effectively alleviate experimental autoimmune uveitis.

Dexamethasone prodrug cyclodextrin aggregates effectively alleviate experimental autoimmune uveitis.

Journal: Colloids and surfaces. B, Biointerfaces

Published: April 02, 2025

Random forest-based model for the recurrence prediction of borderline ovarian tumor: clinical development and validation.

Random forest-based model for the recurrence prediction of borderline ovarian tumor: clinical development and validation.

Journal: Journal of cancer research and clinical oncology

Published: March 30, 2025

Causal Relationship between Gut Microbiota and Endometrial Cancer: A Two-Sample Mendelian Randomization Study.

Causal Relationship between Gut Microbiota and Endometrial Cancer: A Two-Sample Mendelian Randomization Study.

Journal: International journal of medical sciences

Published: February 27, 2025

MRPL13 enhances mitochondrial function and promotes tumor progression in ovarian cancer by inhibiting mPTP opening via SLC25A6.

MRPL13 enhances mitochondrial function and promotes tumor progression in ovarian cancer by inhibiting mPTP opening via SLC25A6.

Journal: Cell death & disease

Published: December 12, 2024

PSAT1 regulated by STAT4 enhances the proliferation, invasion and migration of ovarian cancer cells via the PI3K/AKT pathway.

PSAT1 regulated by STAT4 enhances the proliferation, invasion and migration of ovarian cancer cells via the PI3K/AKT pathway.

Journal: International journal of molecular medicine

Published: October 08, 2024

A predictive model for recurrence in patients with borderline ovarian tumor based on neural multi-task logistic regression.

A predictive model for recurrence in patients with borderline ovarian tumor based on neural multi-task logistic regression.

Journal: BMC cancer

Published: April 10, 2024

PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation.

PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation.

Journal: BMC cancer

Published: September 28, 2022

Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing.

Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing.

Journal: Oxidative medicine and cellular longevity

Published: September 08, 2022

Prognostic biomarker MCP-4 triggers epithelial-mesenchymal transition via the p38 MAPK pathway in ovarian cancer.

Prognostic biomarker MCP-4 triggers epithelial-mesenchymal transition via the p38 MAPK pathway in ovarian cancer.

Journal: Frontiers in oncology

Published: September 02, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026